These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 9144727

  • 21. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 22. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
    Kaewjan K, Srichana T.
    Pharm Dev Technol; 2016 Mar 21; 21(1):68-75. PubMed ID: 25331092
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 25. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
    Yu J, Romeo MC, Cavallaro AA, Chan HK.
    Int J Pharm; 2018 Apr 25; 541(1-2):11-18. PubMed ID: 29454904
    [Abstract] [Full Text] [Related]

  • 26. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A, Amaro MI, Cabral LM, Healy AM, de Sousa VP.
    Int J Pharm; 2016 Mar 30; 501(1-2):124-38. PubMed ID: 26836711
    [Abstract] [Full Text] [Related]

  • 27. Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.
    Louey MD, Van Oort M, Hickey AJ.
    Pharm Res; 2004 Jul 30; 21(7):1207-13. PubMed ID: 15290861
    [Abstract] [Full Text] [Related]

  • 28. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
    Rattanupatam T, Srichana T.
    Drug Deliv; 2014 Sep 30; 21(6):397-405. PubMed ID: 24401124
    [Abstract] [Full Text] [Related]

  • 29. Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.
    Duan J, Vogt FG, Li X, Hayes D, Mansour HM.
    Int J Nanomedicine; 2013 Sep 30; 8():3489-505. PubMed ID: 24092972
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Pharm Res; 2006 Sep 30; 23(9):2200-9. PubMed ID: 16900411
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM.
    Int J Nanomedicine; 2013 Sep 30; 8():275-93. PubMed ID: 23355776
    [Abstract] [Full Text] [Related]

  • 37. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.
    Chew NY, Bagster DF, Chan HK.
    Int J Pharm; 2000 Sep 25; 206(1-2):75-83. PubMed ID: 11058812
    [Abstract] [Full Text] [Related]

  • 38. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO, Corrigan OI, Healy AM.
    Int J Pharm; 2006 Sep 28; 322(1-2):22-30. PubMed ID: 16815654
    [Abstract] [Full Text] [Related]

  • 39. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM, Tucker IG, Das SC.
    Drug Dev Ind Pharm; 2019 Jul 28; 45(7):1205-1213. PubMed ID: 30990097
    [Abstract] [Full Text] [Related]

  • 40. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.
    Xu Z, Mansour HM, Mulder T, McLean R, Langridge J, Hickey AJ.
    J Pharm Sci; 2010 Aug 28; 99(8):3415-29. PubMed ID: 20222025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.